Loading company filing…
Find a company. Follow its revenue through costs and profit.
Coverage includes separate ticker and security records; counts are not unique companies.
Sankey diagram of MUROMACHI CHEMICALS INC.. A complete text table follows the diagram.
Healthy foods add a meaningful consumer-facing third stream, while pharmaceuticals lead operating income.
Swipe to explore
Every category amount is a reported EDINET XBRL fact. Nodes described as arithmetic bridges are calculated residuals and do not imply a separately reported filing line.
Labels and narrative explain the filing. A category marked “arithmetic bridge” or “residual” is calculated from reported totals, rather than a separately reported line.
| Category | Stage | Value | Notes |
|---|---|---|---|
| Pharmaceutical business | 1 | 1.8B | 48.0% of reported total |
| Chemical products business | 1 | 1.3B | 34.1% of reported total |
| Healthy food business | 1 | 660M | 17.9% of reported total |
| Other & rounding | 1 | 0 | 0.0% of reported total |
| Revenues From External Customers | 2 | 3.7B | Reported six-month total · ¥3.7B |
| Operating profit | 3 | 349M | 9.5% operating margin |
| Operating costs & expenses | 3 | 3.3B | Arithmetic residual to reported operating profit |
| Profit before tax | 4 | 336M | Reported pretax result |
| MUROMACHI CHEMICALS is led by pharmaceuticals | 4 | 13.6M | Pharmaceuticals generated ¥1.766bn of external revenue, followed by chemicals at ¥1.256bn and healthy foods at ¥660m. |
| Net profit attributable to owners | 5 | 244M | Reported parent-company result |
| Tax, attribution & other | 5 | 91.8M | Arithmetic bridge to owners' profit |
| From | To | Value |
|---|---|---|
| Pharmaceutical business | Revenues From External Customers | 1.8B |
| Chemical products business | Revenues From External Customers | 1.3B |
| Healthy food business | Revenues From External Customers | 660M |
| Other & rounding | Revenues From External Customers | 0 |
| Revenues From External Customers | Operating profit | 349M |
| Revenues From External Customers | Operating costs & expenses | 3.3B |
| Operating profit | Profit before tax | 336M |
| Operating profit | MUROMACHI CHEMICALS is led by pharmaceuticals | 13.6M |
| Profit before tax | Net profit attributable to owners | 244M |
| Profit before tax | Tax, attribution & other | 91.8M |